✦ LIBER ✦

Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study

✍ Scribed by Burger, R. A.; Sill, M. W.; Monk, B. J.; Greer, B. E.; Sorosky, J. I.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of paclitaxel poliglume

✍ Paul Sabbatini; Michael W. Sill; David O'Malley; Lisa Adler; Angeles Alvarez Sec 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 305 KB

A phase II evaluation of mifepristone in

✍ Thomas F. Rocereto; William E. Brady; Mark S. Shahin; James S. Hoffman; Laurie S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Predictive and prognostic angiogenic mar

✍ Ernest S. Han; Robert A. Burger; Kathleen M. Darcy; Michael W. Sill; Leslie M. R 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 415 KB

Phase II study of bevacizumab and pemetr

✍ Hagemann, Andrea R.; Novetsky, Akiva P.; Zighelboim, Israel; Gao, Feng; Massad, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 264 KB

Predictive value of serum CA-125 levels

✍ Leslie M. Randall; Michael W. Sill; Robert A. Burger; Bradley J. Monk; Barbara B 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 484 KB

A phase II study of vorinostat in the tr

✍ Susan C. Modesitt; Michael Sill; James S. Hoffman; David P. Bender 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 251 KB